On May 18, 2017, DevicePharm and Medical Alley Association co-sponsored an event titled “Communicating Value – Marketing Success In A Value-Driven Environment”. The event, held in the iconic Guthrie Theater in downtown Minneapolis, was attended by 200 members of the Minnesota medical device, biotech, diagnostics, and pharmaceutical community.
On May 1, 2017, DevicePharm announced the opening of our new office in Austin, Texas. This office was developed to serve the growing medical technology industry in Austin, Houston, Dallas, and San Antonio.
Clay Wilemon, DevicePharm CEO and Chief Strategy Officer described the motivation for opening the Austin office, “Texas has over 700 medical device, biotech, diagnostics, and pharmaceutical companies.
On February 22, 2017, Sonex Health announced the successful completion of the first ultrasound-guided carpal tunnel release procedure in the United States using the SX-One MicroKnife™. The SX-One MicroKnife™ is an ultra-low profile surgical device that allows physicians to perform Micro-invasive carpal tunnel release (CTR) surgery through a single micro-incision (4-5 mm) using ultrasound guidance.
The scenario is common. A new medical technology is introduced that potentially improves care and practice economics, but also disrupts conventional care patterns. The question in these scenarios is, “How do we quantify the clinical and economic value and how do we communicate that to clinicians?”
7D Surgical announced today that it has received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and a medical device license from Health Canada enabling the North American commercial launch of its innovative Machine-vision Image Guided Surgery (MIGS™) system for spine surgery, the 7D Surgical System. This breakthrough system is designed to simplify and speed up surgical workflow, increase surgeon control, eliminate intraoperative radiation, and deliver exceptional value.
DevicePharm is pleased to announce Amber Chao’s promotion to Vice President, Group Account Director at DevicePharm. Amber has lead teams that have helped DevicePharm clients successfully launch dozens of market-leading and innovative brands around the globe. She has earned the respect of both clients and colleagues.
DevicePharm, a marketing strategy and integrated marketing solutions firm, was awarded two 2016 International Davey Awards this month for work created on behalf of Bausch + Lomb’s VICTUS® Femtosecond Laser Platform brand and Clarity Medical’s HOLOS IntraOp™ brand.
DevicePharm co-sponsored, along with Medical Alley Association, an interactive panel titled “Medical Device Marketing Through the Eyes of Your Customers”. The event, held on November 10 at the new U.S. Bank Stadium in Minneapolis, was hosted by DevicePharm CEO, Clay Wilemon, and was an overwhelming success.
DevicePharm, along with six other Orange County professional services firms, co-sponsored the 2016 OCTANe LaunchPad ‘Company Of The Year’ award. The LaunchPad Program gave nine early-stage companies the opportunity to present to a panel of investors with the chance to receive a bundle of professional services ranging from brand development to intellectual property, reimbursement, and financial services.
Big Data. The term is ubiquitous in our culture and its importance was validated by the attendance of over 500 people at the leadoff panel during the OCTANe 2016 Medical Device and Investor Forum. The panel, titled “Using Big Data To Improve Patient Outcomes and Reimbursement” was hosted by DevicePharm CEO, Clay Wilemon.